当前位置:首页 - 行情中心 - 圣诺生物(688117) - 财务分析 - 现金流量表

圣诺生物

(688117)

  

流通市值:55.86亿  总市值:55.86亿
流通股本:1.57亿   总股本:1.57亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金181,689,556.36733,108,680.57493,707,682.87346,373,679.06
  收到的税费返还14,399,691.5520,151,491.2917,075,334.4911,170,724.24
  收到其他与经营活动有关的现金7,813,167.5272,990,764.7442,804,558.9545,057,624.53
  经营活动现金流入小计203,902,415.43826,250,936.6553,587,576.31402,602,027.83
  购买商品、接受劳务支付的现金118,622,388.9314,497,155.77251,633,096.52158,552,248.91
  支付给职工以及为职工支付的现金53,510,049151,084,783.43114,208,566.3577,537,054.92
  支付的各项税费11,800,823.1731,595,015.3526,330,978.4223,289,477.52
  支付其他与经营活动有关的现金42,093,123.61150,627,985.07101,312,829.8161,564,661.68
  经营活动现金流出小计226,026,384.68647,804,939.62493,485,471.1320,943,443.03
  经营活动产生的现金流量净额-22,123,969.25178,445,996.9860,102,105.2181,658,584.8
二、投资活动产生的现金流量:
  收回投资收到的现金-19,079,369.2329,621,311.0819,079,369.23
  取得投资收益收到的现金64,791.91526,802.08338,726.96338,726.96
  处置固定资产、无形资产和其他长期资产收回的现金净额-97,545.33--
  处置子公司及其他营业单位收到的现金净额-1,659,467.04--
  收到的其他与投资活动有关的现金26,000,000122,670,00065,000,00065,000,000
  投资活动现金流入小计26,064,791.91144,033,183.6894,960,038.0484,418,096.19
  购建固定资产、无形资产和其他长期资产支付的现金31,471,266.65145,766,800.4999,910,716.9961,413,603.09
  投资支付的现金10,500,00066,000,00070,670,00026,170,000
  支付其他与投资活动有关的现金90,000,000122,670,000112,160,532.9645,160,532.96
  投资活动现金流出小计131,971,266.65334,436,800.49282,741,249.95132,744,136.05
  投资活动产生的现金流量净额-105,906,474.74-190,403,616.81-187,781,211.91-48,326,039.86
三、筹资活动产生的现金流量:
  取得借款收到的现金168,000,000437,905,460.82301,405,460.82236,000,000
  收到其他与筹资活动有关的现金-89,080,000110,000,000-
  筹资活动现金流入小计168,000,000526,985,460.82411,405,460.82236,000,000
  偿还债务支付的现金98,300,000413,030,000238,730,000176,730,000
  分配股利、利润或偿付利息支付的现金4,905,968.5935,995,105.2526,643,208.2522,616,658.45
  支付其他与筹资活动有关的现金6,926,221.4417,633,878.09-55,000
  筹资活动现金流出小计110,132,190.03466,658,983.34265,373,208.25199,401,658.45
  筹资活动产生的现金流量净额57,867,809.9760,326,477.48146,032,252.5736,598,341.55
四、汇率变动对现金及现金等价物的影响-737,838.6-762,029.61-905,097.76-622,703.11
五、现金及现金等价物净增加额-70,900,472.6247,606,828.0417,448,048.1169,308,183.38
  加:期初现金及现金等价物余额281,052,370.34205,482,774.06205,482,774.06205,482,774.06
  期末现金及现金等价物余额210,151,897.72253,089,602.1222,930,822.17274,790,957.44
补充资料:
  净利润-157,889,937.35-88,917,856.49
  资产减值准备-14,873,082.1-8,175,880.74
  固定资产和投资性房地产折旧-54,575,666.79-20,482,661.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-54,575,666.79-20,482,661.62
  无形资产摊销-1,961,618.88-910,584.94
  长期待摊费用摊销-1,473,356.74-581,383.12
  固定资产报废损失-1,531,851.71-1,506,299.49
  公允价值变动损失--248,900-157,000
  财务费用-18,296,093.44-6,120,831.62
  投资损失--1,955,306.77--1,451,653.4
  递延所得税--3,486,480.29--3,877,326.59
  其中:递延所得税资产减少--3,486,480.29--3,877,326.59
  存货的减少--51,208,484.52--8,591,148.14
  经营性应收项目的减少--79,137,548.66-15,980,417.68
  经营性应付项目的增加-57,316,359.92--41,784,891.88
  其他-2,803,520.27--
  现金的期末余额-253,089,602.1-274,790,957.44
  减:现金的期初余额-205,482,774.06-205,482,774.06
  现金及现金等价物的净增加额-47,606,828.04-69,308,183.38
公告日期2026-04-242026-04-242025-10-282025-08-15
审计意见(境内)标准无保留意见
TOP↑